Pulmatrix Inc (PULM)
Pulmatrix Inc (NASDAQ-PULM) is a Healthcare company whose common stock is traded on NASDAQ under the security context of common equity. The company is associated with pharmaceutical development focused on inhaled medicines and related delivery technology for respiratory and other medical uses. Its work centers on drug formulation and product candidates intended for treatment areas such as airway disease, migraine, and other conditions that may be addressed through inhalation-based delivery. As a listed company security, PULM represents equity exposure to Pulmatrix Inc rather than a fund, debt instrument, or other special security type.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-PULM
|
$1.67
|
-1.6% Downside
|
Fair
|
Not available
|
Not available
|
Good
|
0.0%
|
November 5, 2026
|
3.9x
|
6.209 M
|
5.007 M
|
0.0%
|
100.0%
|
-129.2
|
97.0%
|
